2025

Expedience Software Recognized as a Representative Vendor in the 2025 Gartner Market Guide for RFP Response Management Applications

MANCHESTER, N.H., March 04, 2026 (GLOBE NEWSWIRE) -- Expedience Software, a leading provider of proposal automation technology, today announced its…

2 months ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting…

2 months ago

Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

Company to Host Conference Call at 8:30am ET March 04, 2026 07:00 ET  | Source: Kamada Ltd. REHOVOT, Israel, and…

2 months ago

KuCoin Recognized as PoR Transparency Leader in CryptoQuant’s Annual Exchange Leader Report 2025

PROVIDENCIALES, Turks and Caicos Islands, March 4, 2026 /PRNewswire/ -- CryptoQuant has released its Annual Exchange Leader Report 2025, evaluating…

2 months ago

Hisense Leads Global TV Shipments in 2025 Across 100-Inch+ and Laser TVs

QINGDAO, China, March 2, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, has reaffirmed its…

2 months ago

KuCoin Ranks Among Top Three Exchanges in Animoca Brands Research 2025 Listing Report

PROVIDENCIALES, Turks and Caicos Islands, Feb. 28, 2026 /PRNewswire/ -- KuCoin has been ranked among the top three cryptocurrency exchanges…

2 months ago

TraceLink Builds on Transformative 2025 to Scale Agentic Orchestration Across the Global Life Sciences Supply Chain in 2026

Company highlights landmark DSCSA execution, accelerated MINT network growth, and expansion of OPUS Agentic Business SolutionsBOSTON, Feb. 27, 2026 /PRNewswire/…

2 months ago

Orion Group Financial Statement documents 2025 and Remuneration Report published

ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT 27 FEBRUARY 2026 at 11.05 EET         Orion Group Financial Statement documents…

2 months ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…

2 months ago

THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS

Strong share gains and solid growth; operating leverage and cashflow drive deleveragingZURICH, Feb. 25, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT…

2 months ago